New patent expiration for Nabriva drug XENLETA

Annual Drug Patent Expirations for XENLETA Xenleta is a drug marketed by Nabriva and is included in two NDAs. There are four patents protecting this drug. Drug patent litigation for…

The post New patent expiration for Nabriva drug XENLETA appeared first on DrugPatentWatch - Make Better Decisions.

Comments are closed.